Cardlytics, Inc.
Cardlytics, Inc. (CDLX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cdlx · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Hold
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$1.00
Consensus
$1.00
-83.3% upside
Low
$1.00
Median: $1 · Last Close: $5.98
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.84 | ↓ 2.30% |
1-day model range: $5.68–$6. Peak: $6 (-2.30%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CDLX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-08 | Evercore ISI Group | Maintains | In Line→In Line |
| 2025-05-08 | Lake Street | Maintains | Hold→Hold |
| 2025-03-13 | Evercore ISI Group | Maintains | In Line→In Line |
| 2025-03-13 | Needham | Maintains | Hold→Hold |
| 2025-03-13 | Lake Street | Maintains | Hold→Hold |
| 2025-01-17 | Needham | Maintains | Hold→Hold |
| 2024-08-16 | Northland Capital Markets | Downgrade ↓ | Outperform→Market Perform |
| 2024-08-15 | B of A Securities | Downgrade ↓ | Neutral→Underperform |
| 2024-08-08 | Northland Capital Markets | Maintains | Outperform→Outperform |
| 2024-08-08 | Needham | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Cardlytics, Inc. (CDLX) stock. Of the recent 81 rating actions, 4 were upgrades and 15 were downgrades. 15 analysts currently cover CDLX.
Analyst Recommendation Trends
CDLX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$308M
↑ 32.8% YoY
Revenue Next Year
$268M
↓ 13.0% YoY
EPS This Year
$-1.16
EPS Next Year
$-4.07
↑ 252.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CDLX EPS of $-1.16 for the current fiscal year, based on estimates from 2 analysts. The CDLX revenue forecast is $308M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CDLX stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CDLX price target is $1.00 (-83.3% upside), with an analyst consensus of Hold.
The CDLX short-term stock prediction for tomorrow is $5.84 (-2.30%).
Cardlytics, Inc. trades on NASDAQ under the ticker CDLX. The CDLX stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 27% of covering analysts.
Frequently asked questions
CDLX forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month CDLX price target is $1.00, with a high forecast of $1.00 and a low of $1.00. The median price target is shown in the chart above when available. This implies -83.3% potential upside from the current price of $5.98.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.